Items where Author is " Odening Katja E."

Kreifels Paul and Bodi Ilona and Hornyik Tibor and Franke Gerling and Perez-Feliz Stefanie and Lewetag R. and Moss Robin and Castiglione Alessandro and Ziupa David and Zehender Manfred and Brunner Michael and Bode Christoph and Odening Katja E.: Oxytocin exerts harmful cardiac repolarization prolonging effects in drug-induced LQTS.
IJC HEART & VASCULATURE, 40. ISSN 2352-9067 (2022)

Hornyik Tibor and Rieder Marina and Castiglione Alessandro and Major Peter and Baczkó István and Brunner Michael and Koren Gideon and Odening Katja E.: Transgenic rabbit models for cardiac disease research.
BRITISH JOURNAL OF PHARMACOLOGY, 179 (5). pp. 938-957. ISSN 0007-1188 (2022)

Odening Katja E. and Baczkó István and Brunner Michael: Animals in cardiovascular research: important role of rabbit models in cardiac electrophysiology.
EUROPEAN HEART JOURNAL, 41 (21). p. 2036. ISSN 0195-668X (2020)

Hornyik Tibor and Castiglione Alessandro and Franke Gerlind and Perez-Feliz Stefanie and Major Péter and Hiripi László and Koren Gideon and Bősze Zsuzsanna and Varró András and Zehender Manfred and Brunner Michael and Bode Christoph and Baczkó István and Odening Katja E.: Transgenic LQT2, LQT5, and LQT2-5 rabbit models with decreased repolarisation reserve for prediction of drug-induced ventricular arrhythmias.
BRITISH JOURNAL OF PHARMACOLOGY, 177. pp. 3744-3759. ISSN 0007-1188 (2020)

Baczkó István and Hornyik Tibor and Brunner Michael and Koren Gideon and Odening Katja E.: Transgenic Rabbit Models in Proarrhythmia Research.
FRONTIERS IN PHARMACOLOGY, 11. Azonosító: 853-Terjedelem: 18 p. ISSN 1663-9812 (2020)

Major Péter and Baczkó István and Hiripi László and Odening Katja E. and Juhász Viktor and Kohajda Zsófia and Horváth András and Seprényi György and Kovács Mária and Virág László and Jost Norbert László and Prorok János and Ördög Balázs and Doleschall Zoltán and Nattel Stanley and Varró András and Bősze Zsuzsanna: A novel transgenic rabbit model with reduced repolarization reserve: long QT syndrome caused by a dominant-negative mutation of the KCNE1 gene.
British journal of pharmacology, 173 (12). pp. 2046-2061. ISSN 1476-5381 (2016)